Yes Ken, I understand the frustration.
Love how vested a lot of you guys are & am certain it benefits us as shareholders.
The molecule remains as advertised & maybe better. But I am quite impressed with management being that CYDY is still afloat after the NP & Amerex trainwreck.
IMHO, what is truly astounding is how quickly we have gained some semblance of rapport with the FDA. Creditors continue to string us along. Why? Nobody is taking a low ball offer for a quick paycheck. Why not? Obviously suitors will not overpay.
There is much to be done. Just so happy that we no longer feed the shorts with NP CCs full of dangling carrots.
Was hoping todays communication was related to inflammation study rather than increased share count.
I suppose I will buy more to keep it dreamworthy.
Long covid on the cheap was like free money but not a focal point present day.
So much of the covid money has & is still being absorbed by cons that MAYBE someone has decided not to chase it. But the issue is still worthy of DD.
I enjoy your posts.